Biochemical diagnosis of pheochromocytoma: which test is best?
By J. Lenders, Karel Pacak, M. Walther, W. Linehan, M. Mannelli, P. Friberg, H. Keiser, D. Goldstein, Graeme Eisenhofer, David H. Mark. Journal of the American Medical Association (JAMA), 2002
1,210 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Surgery
View Paper: https://www.semanticscholar.org/paper/cbb89abdd177aa3aa700c35edc28ce7ca62cae89
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Surgery
Citations in the corpus
- American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. (2009, neutral): “%) and appears to be the best initial test for screening patients for pheochromocytoma (11 [EL 4], 12 [EL 3]) .”
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. (2014, background): “Five of the 15 studies involved comparisons of plasma free with urine fractionated metanephrines (39, 42, 46, 48, 53).”
- Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine (2004, background): “Montanari R, Costa A, and Beavan MA (1963) Turnover rates of norepinephrine in hearts of mice, rats and guinea pigs using tritiated norepinephrine.”
- The clinically inapparent adrenal mass: update in diagnosis and management. (2004, background): “Although urine metanephrines and VMA have a higher specificity, receiver operating characteristic curves revealed a better test performance for plasma metanephrines than other biochemical tests (185).”